Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.80
+0.08 (0.75%)
Jun 29, 2026, 3:10 PM EDT - Market open

Phathom Pharmaceuticals Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Phathom Pharmaceuticals stock have an average target of 25.67, with a low estimate of 18 and a high estimate of 29. The average target predicts an increase of 137.69% from the current stock price of 10.80.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $18 $25.67 $28 $29
Change +66.67% +137.69% +159.26% +168.52%

Analyst Ratings

The average analyst rating for Phathom Pharmaceuticals stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 888777
Buy 112222
Hold 221111
Sell 000000
Strong Sell 000000
Total 111111101010

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Craig-Hallum
Craig-Hallum
Buy
Maintains
n/a
Buy Maintains n/a n/a Jun 24, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$26
Buy Reiterates $26 +140.74% Jun 17, 2026
Needham
Needham
Buy
Maintains
$28
Buy Maintains $28 +159.26% Jun 1, 2026
Barclays
Barclays
Buy
Maintains
$18
Buy Maintains $18 +66.67% May 15, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$25
Buy Reiterates $25 +131.48% May 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
334.09M
from 175.11M
Increased by 90.79%
Revenue Next Year
539.95M
from 334.09M
Increased by 61.62%
EPS This Year
-0.04
from -2.06
EPS Next Year
1.44
from -0.04
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
--682.00K55.25M175.11M334.09M539.95M
Revenue Growth
---8,001.47%216.93%90.79%61.62%
EPS
-3.89-5.05-3.93-5.29-3.03-0.641.16
EPS Growth
-------
Forward PE
------9.28
No. Analysts -----99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 338.3M 653.2M
Avg 334.1M 540.0M
Low 330.3M 498.8M

Revenue Growth

Revenue Growth 202620272028
High
93.2%
95.5%
Avg
90.8%
61.6%
Low
88.6%
49.3%

EPS Forecast

EPS 202620272028
High 0.09 1.92
Avg -0.04 1.44
Low -0.13 1.17

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.